139 related articles for article (PubMed ID: 25678265)
1. Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Tsiakkas A; Duvdevani N; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 May; 45(5):584-90. PubMed ID: 25678265
[TBL] [Abstract][Full Text] [Related]
2. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Tsiakkas A; Duvdevani N; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 May; 45(5):591-8. PubMed ID: 25653039
[TBL] [Abstract][Full Text] [Related]
3. Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Bredaki FE; Sciorio C; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jul; 46(1):34-41. PubMed ID: 25652769
[TBL] [Abstract][Full Text] [Related]
4. Serum pregnancy-associated plasma protein-A in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Wright D; Silva M; Papadopoulos S; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jul; 46(1):42-50. PubMed ID: 25847022
[TBL] [Abstract][Full Text] [Related]
5. Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Wright A; Wright D; Ispas CA; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jun; 45(6):698-706. PubMed ID: 25581013
[TBL] [Abstract][Full Text] [Related]
6. Serum free β-human chorionic gonadotropin in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Wright D; Papadopoulos S; Silva M; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jul; 46(1):51-9. PubMed ID: 25846870
[TBL] [Abstract][Full Text] [Related]
7. Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Tayyar A; Guerra L; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jun; 45(6):689-97. PubMed ID: 25594620
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum soluble fms-like tyrosine kinase-1 at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia.
Tsiakkas A; Mendez O; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Apr; 47(4):478-83. PubMed ID: 26582564
[TBL] [Abstract][Full Text] [Related]
9. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
[TBL] [Abstract][Full Text] [Related]
10. Prediction of small-for-gestational-age neonates: screening by placental growth factor and soluble fms-like tyrosine kinase-1 at 35-37 weeks.
Fadigas C; Peeva G; Mendez O; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Aug; 46(2):191-7. PubMed ID: 25825848
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum soluble fms-like tyrosine kinase-1 at 22 and 32 weeks in the prediction of pre-eclampsia.
Wright D; Krajewska K; Bogdanova A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):755-61. PubMed ID: 26726123
[TBL] [Abstract][Full Text] [Related]
12. Fetal middle cerebral artery and umbilical artery pulsatility index: effects of maternal characteristics and medical history.
Akolekar R; Sarno L; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Apr; 45(4):402-8. PubMed ID: 25689937
[TBL] [Abstract][Full Text] [Related]
13. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
[TBL] [Abstract][Full Text] [Related]
14. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
[TBL] [Abstract][Full Text] [Related]
16. Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks' gestation.
Lai J; Garcia-Tizon Larroca S; Peeva G; Poon LC; Wright D; Nicolaides KH
Fetal Diagn Ther; 2014; 35(4):240-8. PubMed ID: 24853452
[TBL] [Abstract][Full Text] [Related]
17. Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF.
Tan MY; Wright D; Koutoulas L; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Feb; 49(2):201-208. PubMed ID: 27671370
[TBL] [Abstract][Full Text] [Related]
18. Prediction of small-for-gestational-age neonates: screening by maternal serum biochemical markers at 19-24 weeks.
Lesmes C; Gallo DM; Gonzalez R; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Sep; 46(3):341-9. PubMed ID: 25969963
[TBL] [Abstract][Full Text] [Related]
19. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation.
Wright D; Dragan I; Syngelaki A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Feb; 49(2):194-200. PubMed ID: 27671544
[TBL] [Abstract][Full Text] [Related]
20. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
